CSIMarket
 
Vivus Inc  (VVUS)
Other Ticker:  
 

Vivus Inc

Business Description


Vivus Inc. is a pharmaceutical company that specializes in developing and selling prescription medicines to treat various medical conditions. The company was founded in 1991 and is headquartered in Campbell, California, United States.

The primary focus of Vivus Inc. is on the development of innovative therapies in the areas of metabolic diseases, such as obesity and diabetes, as well as sexual health disorders. The company has a strong commitment to research and development, with a dedicated team of scientists and medical professionals working on discovering and advancing new treatments.

One of Vivus Inc.*s flagship products is Qsymia, which is an FDA-approved prescription medicine for chronic weight management. Qsymia is a combination of two drugs - phentermine, an appetite suppressant, and topiramate, an anti-seizure medication. The drug works by reducing appetite and increasing satiety, thus helping patients with obesity to control their food intake and lose weight.

Vivus Inc. also offers another medication called Stendra, specifically designed to treat erectile dysfunction. Stendra is a phosphodiesterase type 5 (PDE5) inhibitor, which works by increasing blood flow to the penis, resulting in improved sexual function. It is known for its fast onset of action, allowing men to achieve and sustain an erection within 15 minutes of taking the medication.

Apart from these two main products, Vivus Inc. has a pipeline of other potential therapies under development. This includes investigational drugs for pulmonary arterial hypertension (PAH), non-alcoholic steatohepatitis (NASH), and type 2 diabetes.

In addition to its focus on research and development, Vivus Inc. also prioritizes commercialization and marketing of its products. The company employs a sales force that works closely with healthcare professionals to promote awareness and understanding of its medications. They also collaborate with distributors and wholesalers to ensure broad market access for their products.

Vivus Inc. has a global presence, with operations in the United States as well as international markets. The company strives to expand its reach and partnerships to increase the availability of its medicines worldwide.

In terms of regulatory compliance, Vivus Inc. adheres to the strict guidelines set by the U.S. Food and Drug Administration (FDA) and other regulatory bodies. The company conducts rigorous clinical trials to demonstrate the safety and efficacy of its products and seeks regulatory approvals before commercialization.

Overall, Vivus Inc. is a pharmaceutical company dedicated to improving the lives of patients by developing and providing cutting-edge treatments for metabolic diseases and sexual health disorders. With its focus on research, development, and commercialization, the company aims to make a significant impact in the healthcare industry.



View Company Supplier View Company Competition View Company Customers


Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com